Chabot GG[au] - Search Results

Year	Number of Results
1983	2
1984	1
1985	1
1986	1
1987	1
1988	3
1989	3
1990	2
1991	3
1992	2
1993	9
1994	8
1995	6
1996	6
1997	2
1998	1
2000	1
2001	1
2002	2
2003	1
2005	1
2006	1
2007	3
2008	2
2009	1
2010	5
2011	7
2012	7
2013	6
2015	1
2016	2
2022	0

1

[Irinotecan pharmacokinetics].

Chabot GG, Robert J, Lokiec F, Canal P. Chabot GG, et al. Bull Cancer. 1998 Dec;Spec No:11-20. Bull Cancer. 1998. PMID: 9932079 Review. French.

2

Clinical pharmacokinetics of irinotecan.

Chabot GG. Chabot GG. Clin Pharmacokinet. 1997 Oct;33(4):245-59. doi: 10.2165/00003088-199733040-00001. Clin Pharmacokinet. 1997. PMID: 9342501 Review.

3

Metabolism of Flavone-8-acetic Acid in Mice.

Pham MH, Auzeil N, Regazzetti A, Scherman D, Seguin J, Mignet N, Dauzonne D, Chabot GG. Pham MH, et al. Among authors: chabot gg. Anticancer Res. 2016 Aug;36(8):3889-98. Anticancer Res. 2016. PMID: 27466491

4

Clinical pharmacology and pharmacodynamics of irinotecan. A review.

Chabot GG. Chabot GG. Ann N Y Acad Sci. 1996 Dec 13;803:164-72. doi: 10.1111/j.1749-6632.1996.tb26385.x. Ann N Y Acad Sci. 1996. PMID: 8993509 Review. No abstract available.

5

Retinoic acid metabolism and mechanism of action: a review.

Marill J, Idres N, Capron CC, Nguyen E, Chabot GG. Marill J, et al. Among authors: chabot gg. Curr Drug Metab. 2003 Feb;4(1):1-10. doi: 10.2174/1389200033336900. Curr Drug Metab. 2003. PMID: 12570742 Review.

6

Preclinical antitumor activity and pharmacokinetics of irinotecan (CPT-11) in tumor-bearing mice.

Bissery MC, Vrignaud P, Lavelle F, Chabot GG. Bissery MC, et al. Among authors: chabot gg. Ann N Y Acad Sci. 1996 Dec 13;803:173-80. doi: 10.1111/j.1749-6632.1996.tb26386.x. Ann N Y Acad Sci. 1996. PMID: 8993510 Review. No abstract available.

7

Activation of retinoic acid receptor-dependent transcription by all-trans-retinoic acid metabolites and isomers.

Idres N, Marill J, Flexor MA, Chabot GG. Idres N, et al. Among authors: chabot gg. J Biol Chem. 2002 Aug 30;277(35):31491-8. doi: 10.1074/jbc.M205016200. Epub 2002 Jun 17. J Biol Chem. 2002. PMID: 12070176 Free article.

8

[History and new development of screening and evaluation methods of anticancer drugs used in vivo and in vitro].

Bissery MC, Chabot GG. Bissery MC, et al. Among authors: chabot gg. Bull Cancer. 1991;78(7):587-602. Bull Cancer. 1991. PMID: 1912670 Review. French.

9

Development of a liposomal formulation of the natural flavonoid fisetin.

Mignet N, Seguin J, Ramos Romano M, Brullé L, Touil YS, Scherman D, Bessodes M, Chabot GG. Mignet N, et al. Among authors: chabot gg. Int J Pharm. 2012 Feb 14;423(1):69-76. doi: 10.1016/j.ijpharm.2011.04.066. Epub 2011 May 6. Int J Pharm. 2012. PMID: 21571054

10

Lipidic spherulites: formulation optimisation by paired optical and cryoelectron microscopy.

Crauste-Manciet S, Larquet E, Khawand K, Bessodes M, Chabot GG, Brossard D, Mignet N. Crauste-Manciet S, et al. Among authors: chabot gg. Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1088-94. doi: 10.1016/j.ejpb.2013.02.016. Epub 2013 Mar 21. Eur J Pharm Biopharm. 2013. PMID: 23523544

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results